Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

AIFMD Seen as Most Unclear Regulatory Development in the Alternatives Industry

Thursday, January 26, 2012

Lord Paul Myners
Opalesque Industry Update - Over a third of delegates at a recent IMS Group (IMS) regulatory forum expressed the view that the Alternative Investment Fund Managers Directive, remains the most uncertain aspect of financial regulation in terms of its final substance and resultant effect on the industry.

The conference which was held at Bloomberg in London yesterday, played host to over two hundred delegates from the UK asset management and securities industry, including hedge fund managers, private equity firms, fund of funds, prime brokers and lawyers.

According to a survey conducted by IMS, the leading regulation and compliance consultancy, 31% of delegates found that AIFMD raises the most questions when considering the direct impact it will have on fund managers.

Additionally, nearly a quarter of delegates (23%) said that AIFMD will have the most impact in terms of direct cost and necessary change to operating and compliance procedures.

Delegates were also concerned about the impact of UK regulatory change (33%), FATCA (8%), SEC Registration (8%) and MiFID II (7%) on costs to businesses and on implementation of necessary changes to compliance and operating procedures.

Key note speaker Lord Paul Myners said: “The tide of regulation is only going to get stronger and the regulatory landscape will become even more difficult to negotiate. The process of AIFMD is a moveable feast with the ability to throw up constant surprises. The uncertainty surrounding financial regulation is enormous and it is impossible to fully comprehend the impact it will have on businesses. The buyside needs to get better at lobbying on regulation from the outset and actively engage with the regulators.”

Peter Moore, head of regulation at the IMS Group, said: “The results of the survey highlight the need for greater understanding of AIFMD and other regulatory regimes affecting the market. The cost/benefit reports of EU regulation are conspicuous by their absence.”

Press Release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und